Healthcare: Medical Device Winners & Losers

<p>Earnings season continues to heat up and several medical device makers have reported their first-quarter results. In this episode of Industry Focus: Healthcare, host Shannon Jones and Brian Feroldi discuss why <strong>Abiomed</strong> (NASDAQ:ABMD) and <strong>Intersect ENT</strong> (NASDAQ:XENT) are off to a rough start in 2019 and why things couldn't be going better for <strong>Insulet</strong> (NASDAQ:PODD) and <strong>Novocure</strong>(NASDAQ:NVCR).  </p> <p>Stocks mentioned: ABMD, XENT, PODD, and NVCR</p> <p><strong>Check out more of our content here:</strong></p> <ul> <li><a href= "https://www.fool.com/podcasts/?utm_source=podcasts&utm_medium=podcasts&utm_campaign=industryfocus" target="_blank" rel="noopener">TMF's podcast portal</a></li> <li><a href="https://www.youtube.com/user/TheMotleyFool" target= "_blank" rel="noopener">YouTube</a></li> <li><a href="https://twitter.com/mfindustryfocus?lang=en" target= "_blank" rel="noopener">Twitter</a></li> <li><a href="https://m.facebook.com/groups/217114601988296">Join Our Motley Fool Podcast Facebook Group</a></li> <li><a href= "https://www.linkedin.com/company/the-motley-fool">LinkedIn</a></li> <li><a href= "https://www.fool.com/ecap/the_motley_fool/stock-up/?aid=9205&source=isusitsz0000002&ftm_cam=stockup&ftm_veh=sidebarhelp&ftm_mes=signup"> StockUp, The Motley Fool's weekly email newsletter</a></li> </ul>